Updates in CLL: key clinical trials in the frontline and R/R setting, pre-clinical data and MRD VJHemOnc – Video Journal of Hematology & HemOnc 17:23 2 years ago 1 124 Далее Скачать
Driver mutations predicting clinical outcomes upon MRD-guided venetoclax plus ibrutinib in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 4 days ago 34 Далее Скачать
Frontline treatment for CLL: the changing paradigm VJHemOnc – Video Journal of Hematology & HemOnc 1:31 3 months ago 482 Далее Скачать
HOVON 141/VISION trial update: MRD-guided venetoclax + ibrutinib treatment for R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 4:21 1 year ago 185 Далее Скачать
Updates in CLL: Data and Recommendations for Using BTK Inhibitors Medscape 29:27 6 months ago 17 Далее Скачать
There Are Multiple Ways to Treat R/R CLL or R/R MCL: What Would the Experts Do? Medscape 59:02 6 months ago 38 Далее Скачать
Updates in CLL - 2023 Best of Hematology Conference Total Health | Oncology 51:26 1 year ago 5 191 Далее Скачать
Comparison of the different BTK inhibitors available & under investigation in frontline and R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:42 2 years ago 321 Далее Скачать
Key BTK inhibitor trials for the initial treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:51 4 years ago 68 Далее Скачать
The role of MRD in clinical decision-making in R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:35 2 years ago 100 Далее Скачать
Updates on the Phase I trial of rocbrutinib (LP-168), a novel BTKi, for the treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:39 3 days ago 47 Далее Скачать
Opinion on MRD in CLL: routine use or clinical trials? VJHemOnc – Video Journal of Hematology & HemOnc 3:18 6 years ago 240 Далее Скачать
What is your preferred BTK inhibitor in CLL? OncBrothers: Practice-Changing Cancer Discussions 0:58 11 months ago 293 Далее Скачать
Targeted therapy in CLL in 2022 and in the future VJHemOnc – Video Journal of Hematology & HemOnc 1:50 2 years ago 1 568 Далее Скачать
Phase Ib trial of ianalumab plus ibrutinib for CLL VJHemOnc – Video Journal of Hematology & HemOnc 4:08 3 years ago 470 Далее Скачать
Front-line treatment options for CLL | Dr. Jeff Sharman | Oncology Brothers #2023 OncBrothers: Practice-Changing Cancer Discussions 0:49 1 year ago 667 Далее Скачать
Long-term management of CLL for improved outcomes VJHemOnc – Video Journal of Hematology & HemOnc 2:19 3 years ago 338 Далее Скачать
CLL: Long-term updates on ibrutinib and idelalisib HMP Education 25:09 6 years ago 2 193 Далее Скачать
RESONATE-2: ibrutinib and chlorambucil for frontline CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:56 3 years ago 164 Далее Скачать
